By: Alessia Hysa, Gaoqian Feng, Carlota DobaƱo, Jessica L. Horton, David Wetzel, Joshua Waterhouse, Michael Piontek, Sandra Chishimba, Liriye Kurtovic, Natalie Kingsto
Abstract Background The RTS,S/AS01 malaria vaccine was recently approved for implementation in children, but only provides modest and short-lived efficacy against malaria.




